Over the last decade, a rich variety of massively parallel assays have revolutionized our understanding of how biological sequences encode quantitative molecular phenotypes. These assays include deep mutational scanning, highthroughput SELEX, and massively parallel reporter assays. Here, we review these experimental methods and how the data they produce can be used to quantitatively model sequence-function relationships. In doing so, we touch on a diverse range of topics, including the identification of clinically relevant genomic variants, the modeling of transcription factor binding to DNA, the functional and evolutionary landscapes of proteins, and cis-regulatory mechanisms in both transcription and mRNA splicing. We further describe a unified conceptual framework and a core set of mathematical model strategies that studies in these diverse areas can make use of. Finally, we highlight key aspects of experimental design and mathematical modeling that are important for the results of such studies to be interpretable and reproducible.
INTRODUCTION
Deciphering the genetic code was one of the crowning achievements of the early days of molecular biology (64) . By cataloging which amino acids are encoded by each of the 64 possible codons, Nirenberg et al. (101) and others were able to complete the mapping from DNA to mRNA to protein sequence. Subsequently, sequence elements that mark the initiation of transcription (117) and translation (145) were identified. By the mid-1970s, the budding field of molecular biology had good reason to hope that a full determination of how genomic sequence encodes molecular function would proceed along similar lines: One could simply catalog all of the discrete sequence elements that have biological function, then locate where in the genome these functional elements occur.
But nature has not been so eager to reveal the genome's secrets. And in retrospect, the genetic code appears aberrantly simple. Unlike the genetic code, which is a discrete mapping from codons to amino acids, the biological codes governing many other aspects of how cells and organisms work are fundamentally continuous, in the sense that variant alleles produce a graded array of molecular phenotypes. Here, we use the term molecular phenotype in a very broad sense to describe any physical, chemical, or biological property affected by a sequence of interest. The need to understand how sequence encodes the quantitative values of molecular phenotypes arises in a diverse set of problems. For example:
Predicting which variants in the human genome are likely to be pathogenic requires a comprehensive and quantitative understanding of the molecular phenotypes produced by mutation (152) . Transcription factors (TFs) are proteins that regulate gene expression by binding to specific sites encoded in genomic DNA. Understanding the sequence specificities of TFs-that is, which sites a TF will bind and how strong this binding will be-requires quantitative models that integrate sequence information across the length of candidate sites (77) . Proteins typically have multiple molecular phenotypes, including folding energy, enzymatic activity, and expression level. Understanding how protein sequence governs these molecular phenotypes is complicated by the fact that the peptide chain of a protein typically folds into a specific three-dimensional structure, resulting in interactions between amino acids that are distant in the primary sequence. The study of protein sequence-function relationships (42) thus presents experimental and modeling challenges beyond those encountered in the study of TF-DNA binding. Cis-regulatory elements (CREs) are genomic sequences that control gene expression. This control can take place at a variety of steps, including transcript initiation, pre-mRNA splicing, and mRNA decay. CREs typically function by binding multiple regulatory proteins or other trans factors, such as small RNAs, at multiple distinct binding sites. Quantitative models are needed to describe how interactions between these trans factors give rise to CRE activity, but an understanding of the rules that govern these interactions remains largely elusive (79) .
Quantitative sequence-function relationship: the mapping between all possible sequences that a genetic element can have and the quantitative value of that element's molecular phenotype Massively parallel assay: an experimental method that, by using high-throughput DNA sequencing as a readout, can simultaneously measure the molecular phenotypes of a large number of sequence variants of quantitative sequence-function relationships, not only because they generate massive data sets but also because the data they produce can be focused on specific biological contexts (as opposed to genome-wide) both in vitro and inside of cells.
Here, we provide a high-level review of massively parallel assays and the ways in which the data produced by these assays can be used to characterize quantitative sequence-function relationships. We emphasize the shared strategies used in HT-SELEX, DMS, and MPRA experiments, as well as commonalities in the quantitative modeling strategies used to analyze the resulting data. We also discuss the big-picture opportunities that these new approaches present. For human health, massively parallel assays may allow the creation of extensive atlases of genetic variants in human disease genes and key regulatory regions, thus providing a comprehensive solution to the problem of genetic variant interpretation (56, 152, 169) . In basic biology, these technologies provide a general strategy for probing the functional architecture of a wide range of genetic elements. Along the way, we highlight impediments to progress in these two areas and suggest potential ways of overcoming these difficulties.
MASSIVELY PARALLEL ASSAYS
Massively parallel assays all follow a shared schema (Figure 1a) . First, one constructs a library of variants for a genetic element of interest, such as a TF binding site, a protein-coding sequence, or a CRE. This library is then used as input to an experiment that outputs one or more bins of sequences, with the enrichment or depletion of each sequence in each bin being determined by the value of a specific molecular phenotype. The input library (bin 0) and each output bin (bin 1, bin 2, etc.) are sequenced, and the resulting number of times that each variant is observed in each bin is used to quantify that variant's molecular phenotype. The ultrahigh-throughput nature of modern DNA sequencing makes it possible to simultaneously assay thousands to millions of sequence variants in this manner.
Within this shared design, a broad array of different assays have been developed by mixing and matching different binning strategies with different variant libraries. Commonly used binning strategies include in vitro binding, selective cellular growth, fluorescence-activated cell sorting, and mRNA sequencing (Figure 1b-e) . Commonly used variant library formats include genomic, element-shuffle, element-swapping, element-scanning, systematic mutation, scattered mutation, randomized window, and fully random libraries (Figure 2) .
Many different methods for constructing variant libraries have also been described. Classic methods include the digestion and cloning of bulk genomic DNA, standard DNA synthesis with nucleotide mixtures, and error-prone PCR. Commercially available oligo pools, in which approximately 10 3 -10 5 individually specified DNA sequences are synthesized, have greatly increased the flexibility with which libraries of sequences less than approximately 150 base pairs in length can be designed (95, 142) . New methods for high-throughput directed mutagenesis (37, 170, 174) and high-throughput gene synthesis (115) have also opened up previously inaccessible possibilities for long sequence libraries. And, importantly, high-throughput landing-pad integration methods (90) and template-directed mutagenesis using CRISPR/Cas9 (34, 141) are enabling the investigation of large CRE libraries in realistic chromosomal contexts.
This ability to freely combine libraries of different types with different high-throughput enrichment strategies has led to a proliferation of similar assays developed independently by different groups. This burst of creative work has left in its wake a veritable alphabet soup of assay names. To emphasize the shared concepts and strategies behind these approaches, we have organized these methods into three broad classes: HT-SELEX, DMS, and MPRA. 
Figure 1
Experimental strategies used in massively parallel assays. (a) In the general form of a massively parallel assay, a library of pooled sequences serves as input to an experiment (box). This experiment then outputs sequences into one or more bins in a manner that depends on each sequence's measured molecular phenotype. The sequences in each bin are then tallied using high-throughput DNA sequencing. (b) In an HT-SELEX experiment, a library of candidate DNA binding sites are incubated with a TF of interest, after which TF-bound DNA is isolated and sequenced. (c) In a DMS experiment, protein-coding sequences are selected according to a specific molecular phenotype, such as cellular growth rate. (d) In a typical sort-seq MPRA, a library of variant CREs is used to drive the expression of a fluorescent reporter gene. Cells expressing this reporter are sorted into bins using fluorescence-activated cell sorting, and the CREs in each bin are then sequenced. (e) In a typical RNA-seq MPRA, a library of variant CREs drives the expression of mRNA that contains CRE-specific barcodes (circles), which are then sequenced and tallied. Abbreviations: CRE, cis-regulatory element; DMS, deep mutational scanning; HT-SELEX, high-throughput SELEX; MPRA, massively parallel reporter assay; TF, transcription factor.
High-Throughput SELEX
Much of what is known about protein-DNA and protein-RNA binding specificity has been learned using high-throughput microarray techniques, such as protein-binding microarrays (15) and RNAcompete (120) . But over the last decade, HT-SELEX (Figure 1b ) has emerged as a simple and highly accessible alternative for assaying binding specificity (160) . HT-SELEX is an adaptation of the classic SELEX method (166) flanked by constant DNA that enables amplification. This DNA library is then incubated in vitro with a TF of interest, after which TF-bound DNA is isolated and sequenced. As in the standard SELEX procedure, TF-bound DNA can be amplified and used as input for additional rounds of selection if desired. HT-SELEX can be performed in a variety of ways depending on the system of interest and the goals of the study. The use of random DNA libraries allows one to determine the binding specificities for many TFs in parallel without needing to tailor each library to each individual TF (62) . Alternatively, by using DNA libraries in which one or more fixed TF binding sites are partially mutagenized, studies have been able to quantify TF specificity at high precision (187) . HT-SELEX methods have also been developed for assaying the specificity of RNA-binding proteins (50) . Escherichia coli one-hybrid is a method that is conceptually similar to HT-SELEX, except that TF-DNA binding is assayed in living E. coli cells using selective growth (179) . Recent work has also explored the possibility of coupling microfluidic devices with high-throughput DNA sequencing (57, 78) , potentially enabling measurements of binding kinetics. 
Deep Mutational Scanning
We use the term DMS to describe massively parallel mutagenesis studies on proteins and other macromolecules (such as tRNAs) that have complex 3-D structures. Most DMS libraries are constructed to probe the effects of single amino acid substitutions generated either randomly (e.g., using error-prone PCR) (41) or through systematic mutational scanning (174) . The study of epistasis between mutations has been a common theme in DMS studies and has been pursued using scattered mutation libraries (136) , systematic pairwise mutation libraries (104, 134) , and short randomized window libraries (116, 175) . An emerging strategy is the use of DMS experiments to assay libraries of protein sequences engineered to have specific properties, e.g., to study functional constraints on unstructured protein domains (151) . These experiments are likely to benefit from new methods for synthesizing large libraries of synthetic genes (115) . Many different protein selection procedures have been used in DMS experiments. Protein display methods select for buffer-facing proteins that are able to bind a ligand of interest. Among such methods are phage display (41), yeast display (2, 75, 121) , mammalian cell display (40) , and RNA display (104) . The selection of cells based on their ability to express a fluorescent reporter gene has also proven useful (116, 136, 151) . Another common DMS strategy is to select for growth (Figure 1c) , e.g., in viral hosts (165, 177) , bacteria (94) , yeast (53) , or mammalian cells (92) . Finally, while most DMS studies have focused on proteins, several have also focused on structural RNAs, such as tRNAs (29, 81, 118) .
Massively Parallel Reporter Assays
The term MPRA describes a diverse class of assays used to interrogate many different types of CREs in a diverse set of biological systems. These assays mix and match different experimental strategies (Figure 1) with CRE libraries of different types (Figure 2) . Here, we briefly review the wide range of investigations that have been enabled by MPRAs, highlighting in each case some early relevant work; for a more detailed review of MPRA technology, see Reference 79.
MPRAs have been developed in a wide range of systems, including in vitro expression systems (112) , bacteria (69) , yeast (142) , insect cells (5), mammalian cell culture (95) , intact organs (76) , and live animals (111) . These assays have been used to study many different types of CREs, including promoters (69, 112) , enhancers (76, 95, 111) , the 5 and 3 untranslated regions (UTRs) of mRNAs (31, 103, 140) , and pre-mRNA sequences that regulate splicing (9, 129, 173) . Most MPRAs use either a sort-seq strategy or an RNA-seq strategy. Sort-seq MPRAs (Figure 1d ) couple gene expression to a fluorescent protein readout (69, 113) . Fluorescence-activated cell sorting is then used to sort cells based on expression level, after which the variant CREs in each sorted bin are sequenced. Alternatively, RNA-seq MPRAs (Figure 1e ) use the sequencing of expressed mRNA to measure activity. This technique often requires the inclusion of CRE-specific barcodes in expressed transcripts (76, 95, 111, 112) , but such barcodes are not always necessary (5, 9) . In some cases, it is useful to couple RNA-seq MPRAs with techniques that provide other information about the mRNA transcript, such as start site location (168) or the presence of an alternatively spliced exon (9, 129, 173) . Less prevalent but no less useful are cell-growth-based methods, which have been used for both MPRAs (26) and MPRA-like studies of DNA replication origins (83).
GENOMIC VARIANTS
One of the most potentially impactful applications of massively parallel assays is to address the problem of variant interpretation in whole-genome or whole-exome sequencing (56, 152, 169) . The difficulty here is the frequent observation of mutations in human disease genes for which Existing approaches in medical genetics have limited utility for addressing this problem because of the individual rarity of most variants. Statistical approaches such as genome-wide association studies can only identify variants at high enough frequencies to be observed in multiple individuals with the disease phenotype, whereas many VUSs from whole-genome or whole-exome sequencing studies have never been previously observed (56, 152) . For similar reasons, because of the rarity of VUSs, classical methods such as pedigree analysis within multiple affected families cannot be employed.
While empirical approaches are hampered due to the rarity of individual variants, current computational approaches (164) also appear to have only limited utility. Such methods typically rely on some subset of population-genetic data, functional-genomic data, signatures of evolutionary conservation, structural data, and existing disease annotations. In practice, however, these models suffer from a lack of precision, wherein many variants identified as deleterious do not display a corresponding phenotype (49, 96, 119, 162) . In a recent community-organized prediction challenge, these methods also demonstrated only a moderate ability to predict the quantitative effects of missense mutations (182) .
As a result, there is currently an important unmet need for determining the effects of VUSs. Massively parallel assays, which in this context are also referred to as multiplex assays of variant effects (MAVEs), have the potential to help address this need (152, 169) . Indeed, there is a strong precedent in medical genetics for the utility of laboratory-based functional assays (125) , and established, robust, and reproducible functional assays can already provide strong evidence for or against pathogenicity under current clinical guidelines (122) . Provided such methods can be developed that match the performance of low-throughput functional assays, comprehensive massively parallel assays of variants in the most clinically relevant and actionable disease genes would go far in addressing the difficulties presented by VUSs.
Massively Parallel Assays of Human Disease Genes
Several different strategies have used massively parallel assays to measure the functional effects of variants in human disease genes. One approach is based on measuring the activity of a reporter gene. For instance, an influential study by Majithia et al. (88) assayed the impact of all possible missense mutations on the protein PPARγ via changes in the expression of CD36, a downstream target of PPARγ . However, like many functional assays, this experimental design is specific to a particular gene of interest, and a different experimental methodology would be needed for each gene assayed in this manner.
A distinct approach that partially overcomes this difficulty is to use complementation assays. Here, one measures cellular growth rate, typically in yeast or a human cell line, using a genetic background where the endogenous locus has been knocked out. The deletion of the endogenous locus results in a measurable fitness defect that is then ameliorated by functional library variants. Sun et al. (162) provided an important proof of concept for this approach by establishing that complementation assays could be used to characterize the effects of previously annotated mutations in 22 human disease genes. In a follow-up paper, Weile et al. (170) performed high-throughput assays on several of the corresponding proteins (UBE2I, TPK1, and CALM1) and used a machine learning approach to predict the effects of all missense variants therein. GFP (EGFP) and comprehensive variant libraries for the proteins PTEN and TPMT, then assayed the impact of mutations by measuring steady-state protein abundance. The rationale behind this approach is that destabilizing mutations will decrease abundance, e.g., through the targeted degradation of misfolded protein.
Perhaps the best-studied model system for massively parallel assays of human disease genes is the BRCA1 RING domain. This critically important protein domain has been investigated using several different experimental strategies, including a phage-display-based ubiquitination assay (154), a yeast two-hybrid binding assay (154), a GFP-based reporter assay for homologydirected DNA repair (153) , and a growth rate readout in a haploid human cell line in which BRCA1 has become an essential gene (35) . Although all of these assays could likely be further improved, the growth rate assay (35) , which uses CRISPR/Cas9 editing of the endogenous BRCA1 locus, currently appears to have the best performance in distinguishing known pathogenic variants from known benign variants.
Improvements to Experimental Methods
As shown by the discussion above, current efforts to prospectively assess the effects of mutations in human disease genes appear promising. Nevertheless, substantial improvements in the reproducibility and rigor of these experiments can likely be achieved by incorporating best practices from other fields. In particular, both the area of differential expression analysis in RNA-seq studies (22) and the field of experimental evolution (43) have established standardized methods (described below) for how to reliably measure fold changes in abundance between libraries or time points.
First, studies commonly report enrichment scores or other experiment-specific, semiquantitative measures that are not directly comparable across genes, laboratories, or assays. Often, however, these scores can be replaced by measurements in inherently meaningful units. For instance, complementation assays and growth assays generally measure growth rates (i.e., cell divisions per hour), and there are standard methods from experimental evolution and microbiology for estimating these rates as well as differences between them, i.e., selection coefficients (43) . Such methods are already incorporated into the measurement procedures of some reported assays, such as EMPIRIC (53), Enrich2 (132) , and FiT-seq (82) . Similarly, studies of protein-ligand binding should report absolute dissociation constants, as in Tite-seq (2) .
Second, experiments should include both controls and standards. They should also feature an appropriate degree of replication (43) and, when possible, multiple time points (93) . Currently, DMS experiments often use the distribution of synonymous and nonsense mutations as internal controls, but the interpretation of these distributions is complicated by the fact that synonymous mutations need not be neutral, e.g., if they affect translational rates or splicing. A better idea is to incorporate an allelic series of variants with a range of known values for the molecular phenotype of interest. For example, a massively parallel assay based on cellular growth might include a small number of variants whose growth rates have already been measured in a low-throughput manner. This inclusion of an allelic series not only enables calibration (e.g., between enrichment scores and growth rates) but can also reveal important features of the experiment that would not otherwise be apparent, such as saturation. Furthermore, because patients care deeply about the uncertainty in what is known for their specific genomic variant, the concordance between replicate experiments should be measured in terms of the error bars on the values assigned to individual variants, rather than collective measures like the rank correlation across all measurements.
Third, improved best practices for both DNA sequencing and the inference of frequency changes from read counts should be followed. These practices include the use of spike-in controls We feel that such methodological improvements are critical from the patient's perspective. The overall landscape of genetic disease is complex and filled with uncertainty. Even diseases commonly classified as having a simple Mendelian basis can show substantial variation due to variable expressivity and incomplete penetrance (23) . Moreover, the phenotypic variation for individuals harboring the same mutation can be driven by both genetic and environmental factors (23) , and while this genetic influence may sometimes arise due to other mutations at the same locus (21), it is likely that most diseases thought to be monogenic are in fact influenced by multiple loci spread across the genome (65) . High-quality biochemical assays thus play a critical role, pushing back the boundary of uncertainty and providing patients with simple and clear facts. We may not be able to tell patients whether they (or a loved one) will or will not experience disease symptoms, but at least we can tell them whether they harbor a specific variant, whether this variant disrupts the biochemical function of the gene, and what the effects of this variant are in simple model systems. In keeping with the emphasis under current clinical guidelines of incorporating multiple lines of evidence in coming to a diagnosis (122), we recommend reporting the measured quantities for particular variants to patients and clearly distinguishing them from imputed scores (170) or probabilities of pathogenicity estimated using statistical models (88).
PROTEIN-DNA AND PROTEIN-RNA INTERACTIONS
We now move from applications in human health to questions in basic science. Rather than focusing on the effects of individual mutations, the goal here is to use complex libraries of variantsoften including double, triple, and higher-order mutations-to interrogate specific genetic elements. One area where this approach is essential is the study of sequence specificity in protein-DNA and protein-RNA interactions. In this section, we review key concepts in the quantitative modeling of sequence-function relationships within this biological context. We focus primarily on TF-DNA binding, which historically has been a focal point for efforts to understand how quantitative information is encoded within the genome. We discuss other select problems as well, including nucleosome formation, splice site recognition, and the role of RNA secondary structure in protein-RNA interactions.
Why are quantitative models needed for understanding binding specificity? TFs, like most other DNA-and RNA-binding proteins, recognize a wide range of sequences other than just their strongest binding sites. Consider CRP, an activator in E. coli that binds to DNA sites approximately 22 base pairs in length (Figure 3a) . CRP recognizes far more sequences than just its strongest binding site (shown in Figure 3b ). This binding site degeneracy can be roughly described by an International Union of Pure and Applied Chemistry (IUPAC) motif (Figure 3c) , which specifies only the most common bases at each position in the binding site. However, such a representation is unable to account for the fact that different binding sites often have functionally important differences in binding affinity (e.g., 61). In panel g, the character heights represent individual nucleotide weights. In panel h, the height of each base represents the probability of that base occurring at that position in a binding site. In panel i, the total height of each stack of characters quantifies the importance of a nucleotide position using concepts from information theory, while the relative height of each base represents the probability of that base occurring at that position. Abbreviations: IUPAC, International Union of Pure and Applied Chemistry; PSAM, position-specific affinity matrix; PSSM, position-specific scoring matrix; PWM, position weight matrix; TF, transcription factor.
Structural Predictions and the Need for Quantitative Models
To understand the quantitative determinants of TF-DNA binding, it is helpful to think about the effects that mutations have on the structure of a TF-DNA co-complex. A change from one nucleotide to another at any position in the DNA sequence will result in small changes in the atomic 20 . 10 Kinney positions within this structure, a corresponding change in the Gibbs free energy of binding (denoted G), and thus a change in the affinity of that binding site. In principle, a biophysical analysis of co-complex structures should be able to predict these changes and thus provide a quantitative description of TF specificity. And indeed, making such predictions has been the focus of substantial research (63, 77) . But this analysis is exceedingly difficult in practice, in large part because the energy scale that determines binding affinity (k B T = 0.62 kcal/mol at 37°C) is very small relative to the scale of the individual chemical interactions involved in complex formation. For example, CRP is estimated to form 31 hydrogen bonds with DNA in the co-complex structure shown in Figure 3a Quantitative modeling provides an alternative means of understanding TF specificity, one that is largely orthogonal to structure-based approaches. A quantitative model is an abstract mathematical function that takes a biological sequence as input and outputs a numerical quantity known as a score. Such models depend on parameters, the values of which must ultimately be inferred from data. Early successful models of TF binding were built from sequence alignments of (often remarkably few) binding sites (159) . Now, however, a variety of high-throughput assays can provide sufficient data for developing quantitative models that are highly complex (77) . We now review these different types of models and the strategies used to infer their parameters.
Functional Models Versus Generative Models
There are two conceptually distinct types of quantitative models: functional models and generative models. Functional models aim to predict the values of molecular phenotypes; generative models, by contrast, seek to describe the probabilities of observing different sequences within functional genetic elements.
In the context of TF-DNA interactions, the score produced by a functional model usually represents the G of binding. The simplest form of such models is called an energy matrix, also known as a position-specific affinity matrix (PSAM; see Reference 38) . Energy matrices assume that each position within a binding site contributes independently to the value of G. The parameters of an energy matrix are the individual energy contributions of each possible base at each nucleotide position and are conventionally denoted by G. Note that favored bases have lower (i.e., more negative) G values, since lower energy corresponds to stronger binding. Figure 3d illustrates an energy matrix for CRP that was determined by Kinney et al. (69) using data from a sort-seq MPRA.
The score produced by a generative model of TF specificity usually represents the log odds that a functional binding site, as opposed to random DNA under no selective pressure, will have a given sequence. The most common realization of such models is known as a weight matrix, although the terms position weight matrix (PWM) and position-specific scoring matrix (PSSM) are also commonly used (158) . Each nucleotide contributes additively to the overall weight matrix score via a parameter called a weight. Figure 3e shows a weight matrix for CRP computed using an alignment of the 358 annotated CRP binding sites in the E. coli genome (135) . We refer readers to other reviews (77, 158) for a description of how weight matrices are constructed from alignments of binding sites such as this.
In two classic papers, Berg & von Hippel (13, 14) proposed an intriguing connection between energy matrices and weight matrices, thus linking functional and generative models of TF binding. selection. Stormo and colleagues (52) later presented an alternative rationale for this connection based on an in vitro thought experiment. Empirically, this connection between energy matrices and weight matrices has turned out to be remarkably strong. Indeed, the energy matrix from Figure 3d is almost identical to the weight matrix from Figure 3e , save for an overall multiplicative factor. Nevertheless, functional models and generative models do represent very different things, and their equivalence should not be taken for granted. In particular, the in vitro argument relating energy matrices and weight matrices breaks down when TF concentrations are high (130) . For this and other reasons, multiple groups have argued that functional models are to be preferred over generative models when practicable (38, 70, 130, 183 ).
Sequence Logos
Sequence logos provide an evocative way to visualize simple models such as energy matrices and weight matrices. Here, we describe four different kinds of sequence logos that are commonly used in the literature. Figure 3f shows an energy logo (38) for CRP, where the character heights represent the G parameters of the energy matrix from Figure 3d . The weight logo in Figure 3g similarly illustrates the parameters of the weight matrix model from Figure 3e . Both of these logos contain the same information as their respective heat-map representations but are easier for many readers to interpret. The probability logo in Figure 3h provides a somewhat more intuitive, though mathematically less direct, way of visualizing a weight matrix: The height of each base is the probability of that base occurring at that position in a binding site. Information logos (e.g., Figure 3i ) provide yet another way to graphically represent weight matrices. The total height of each stack of characters quantifies the importance of a nucleotide position using a quantity from information theory called Kullback-Leibler divergence (which has units of bits), while the relative heights of characters within a stack reflects their relative probabilities. Information logos were the first type of sequence logo described in the literature (138) and are still widely used (25, 77) . However, they tend to underrepresent the importance of nucleotide positions that are less tightly constrained.
Modeling Epistatic Interactions
Energy matrices and weight matrices are examples of additive models: They assume that each position within a sequence contributes independently to that sequence's overall score. The potential pitfalls of this independence assumption are well recognized, and substantial effort has gone into developing quantitative models that can express epistatic interactions between positions (77) . One way to model epistatic interactions is to make use of sequence features that integrate information across multiple positions (see Figure 4) . The simplest type of epistatic model is the neighbor model, also known as a dinucleotide model, in which the score is a sum of contributions from sequence features that represent adjacent dinucleotides. One notable example of a neighbor model in the literature was proposed by Segal et al. (139) for describing the positioning of nucleosomes in yeast. Pairwise models are somewhat more complex than neighbor models, as they include contributions from sequence features that represent both adjacent and nonadjacent pairs of positions. Two well-known examples of pairwise models were proposed by Yeo & Burge (180) to describe 3 and 5 splice sites in the human genome. Neighbor and pairwise models are naturally generalized by higher-order models, which incorporate contributions from three or more positions at a time. Higher-order models in which coupled positions are contiguous are also referred to as k-mer models. In the TF modeling competition organized by Weirauch et al. (172) , k-mer models performed especially well on TFs that exhibited multiple distinct DNA-binding motifs.
20.12
Kinney An alternative means of incorporating epistatic interactions is based on the observation that TFs recognize sequence-dependent aspects of DNA geometry, rather than just specific combinations of nucleotides (127) . To facilitate the construction of models that reflect this aspect of TF specificity, Zhou et al. (186) used coarse-grained molecular dynamics simulations to tabulate values for the minor groove width, helical twist, propeller twist, and roll that occur near the center of all 512 possible DNA pentamers within free (i.e., non-TF-bound) B-form DNA (Figure 4) . This information can be used to supplement additive models of TF specificity (185) , yielding what are commonly referred to as DNA shape models. For similar reasons, models of protein-RNA binding often incorporate predictions of what the RNA secondary structure would be in the absence of the RNA-bound protein (66, 91, 105) .
A A T G T G A C A T A T G T C A C A C T T
One difficulty with epistatic models is that the number of model parameters grows rapidly as interaction order increases. For example, consider a TF that recognizes binding sites 10 base pairs in length. An additive model for this TF will have 40 parameters, a neighbor model will have 144 parameters, a pairwise model will have 720 parameters, a third-order model will have 7,680 parameters, and so on. As the number of parameters increases, so does the risk of overfitting. Overfitting can often be counteracted by using standard regularization methods (124) or sparse models, in which most of the parameters are constrained to be zero (143).
The above-described models are all examples of linear models because the scores they return are linear combinations of model parameters (see Equation 2 in the sidebar titled Mathematical Forms of Sequence-Function Relationships). Global epistasis models provide an important generalization of the linear model concept: The score of a global epistasis model is a nonlinear transformation of the score of a linear model (Equation 3 in the sidebar). Global epistasis is natural in the study of TF specificity because the fraction of time a DNA site is bound by a TF is a highly nonlinear function of G (158) . Evolutionary fitness, which governs the evolution of TF binding sites, has also been observed in some cases to be a nonlinear function of G (100). 
MATHEMATICAL FORMS OF SEQUENCE-FUNCTION RELATIONSHIPS
Let S denote an input sequence, L be the length of that sequence, and C be the number of possible characters at each position in S (C = 4 for DNA and RNA, C = 20 for proteins). An additive model relies on C × L features, each written as F ci (S), where F ci (S) = 1 if character c occurs at position i in sequence S, and F ci (S) = 0 otherwise. The score of an additive model is computed as
where θ ci denotes the model parameter corresponding to feature F ci . More generally, a linear model of a sequencefunction relationship is defined as any model that can be written as
where K is the number of sequence features in the model, F k (S) is the kth sequence feature (which is allowed to take an arbitrary value for each sequence, not just 0 or 1), and θ k is the corresponding model parameter. Global epistasis models include an additional nonlinearity and can be expressed as
where f linear (·) is a linear model and g(·) is a nonlinear function.
Learning Models from Data
Just as important as the mathematical form of a quantitative model is the way in which the values of that model's parameters are learned from data. Parameter inference is a particularly challenging problem because TF-binding experiments almost always measure binding to DNA sequences that are much longer than a single binding site. A large number of motif-finding algorithms, using a wide range of machine learning strategies, have been proposed for this purpose (77) . Generative models of TF specificity are often inferred using methods from the field of signal processing, such as the expectation-maximization algorithm (10) . Functional models, on the other hand, can be learned using statistical inference methods such as maximum likelihood (38, 183) , support vector machines (45), or mutual information maximization (8, 32, 70) . The proper way to treat long DNA sequences within functional models, however, is less obvious than it is in generative models. One attractive approach that is becoming increasingly popular (38, 124, 131, 183) is to use thermodynamic models (16, 114, 144) , which rely on the equations of statistical physics, to predict the average number of TF molecules that will simultaneously bind to a long DNA sequence.
Outlook
The problem of TF-DNA binding has spurred the development of a rich variety of methods for modeling sequence-function relationships. At present, there appear to be sufficiently powerful experimental and computational methods for characterizing the in vitro specificities of individual TFs (77 (55) . In eukaryotes, TF-DNA binding is often contingent on binding sites being present in nucleosome-free regions of DNA, and the rules that govern nucleosome positioning remain incompletely understood (161) . Epigenetic modifications, such as cytosine methylation, also strongly affect TF binding to DNA (27) . Moreover, the interactions of a TF with other DNAbound proteins (148) or with non-DNA-binding cofactors (147) can affect that TF's specificity in emergent and sometimes surprising ways. One exciting and increasingly popular strategy that might help to answer some of these lingering questions is the use of deep learning techniques (48) for modeling protein-DNA and protein-RNA specificity. Of particular interest are convolutional neural network models, which can integrate binding signals across long sequences in a highly flexible manner (3). These models have been proposed for characterizing the complex context dependence of TF-DNA binding to chromatin in vivo (68, 184) . In the context of protein-RNA binding, these models have shown remarkably good performance, including the ability to capture the effects of RNA secondary structure (73) . Convolutional neural networks are less readily interpreted than thermodynamic models, but efforts to improve the interpretability of these and other deep learning models are under way (74, 146) .
PROTEINS
In some ways, the relationship between an amino acid sequence and its biological function is quite different from the relationship between a DNA binding site and its affinity for a TF. First, the amino acid alphabet is much larger than the nucleotide alphabet (20 proteinogenic amino acids versus 4 deoxyribonucleotides), meaning that random protein sequences have only 5% rather than 25% sequence similarity. Moreover, protein sequences tend to be much longer than TF binding sites, typically having tens to thousands of positions rather than just 5-30 positions. Thus, while it is often experimentally feasible in the context of TF specificity to exhaustively explore sequence space, it is typically impossible to do so for proteins since, e.g., there are 10 130 possible amino acid sequences of length 100. And within this much larger space of possible sequences, the fraction of functional sequences is far smaller. For example, while a few kilobases of random DNA sequence will typically contain at least one binding site for any given eukaryotic TF, it has been estimated that only approximately 1 in 10 11 protein sequences will exhibit substantial ATP-binding activity (67) . Finally, whereas the molecular phenotype of a TF binding site can often be fully described by a single number-its binding affinity-each protein will typically have many functionally and biophysically distinct molecular phenotypes, including folding energy, enzymatic activity, ligand or cofactor binding affinity, and responsiveness to allosteric regulation.
Despite these differences, current techniques for modeling and understanding sequencefunction relationships in proteins are very similar to those used for TF binding sites. These similarities arise for three main reasons. First, because of the size of protein sequence space and the rarity of functional protein sequences, models of protein sequence-function relationships tend to focus on relatively minor perturbations to a sequence known to be functional. Such perturbations tend to maintain the 3-D structure of the protein and the ability to align one protein sequence to another. As a result of this restriction in scope, each position typically has a relatively consistent functional role across sequence backgrounds, and so additive models with one parameter for each possible amino acid at each position often provide good baseline performance. Second, the simplest thermodynamic models of protein folding are very similar to thermodynamic models of TF binding in that the probability of a protein being folded is a nonlinear function of G, with G itself being additive (178 focus on DNA binding, proteins can bind many different types of ligands, substrates, and cofactors. Studying how amino acid sequence influences the specificity of these interactions has been a major focus of DMS experiments (1, 156) , sometimes even enabling measurements of binding specificity in physical units (2).
Evidence For and Against the Additive Folding Energy Hypothesis
Starting in the mid-2000s, a synthetic theory emerged from the work of several different groups that attempted to explain a diverse set of observations about the thermodynamics and evolution of natural proteins using simple assumptions about protein sequence-function relationships. These assumptions were as follows: (a) For random mutations, most fitness effects are due to defects in protein folding; (b) the fraction of time a protein spends properly folded is a logistic function of the free energy of folding G (i.e., the two-state model); and (c) the stability effect of any given mutation, G, is well conserved across sequence backgrounds and can be treated as additive. These parsimonious assumptions were then used to explain and self-consistently describe a wide variety of phenomena, including frequencies of functional sequences in mutagenesis libraries (19) , patterns of epistasis (46, 47) , the distribution of observed fitness effects of mutations and the marginal thermodynamic stability of proteins (46, 178) , and many features of molecular evolution (46, 181) , such as the overdispersed molecular clock (i.e., the observation that amino acid substitutions occur in a temporally clustered manner) (18) .
This additive folding energy hypothesis makes strong predictions for the types of models that should be able to describe protein sequence-function relationships. In particular, it predicts that protein sequence-function relationships should be well approximated by a global epistasis model (72, 107, 133, 157) in which fitness is a monotonic function of an underlying additive model (Equation 3) and the underlying additive trait is proportional to the free energy of folding G. Moreover, a key qualitative prediction of such a model is that any given mutation should have either a beneficial or deleterious effect across all genetic backgrounds, even if the magnitude of the effect is background dependent (and might include neutrality on, e.g., highly stable backgrounds). This is because, under the additive folding energy hypothesis, a stabilizing mutation will always increase the fraction of time the protein is properly folded, which will always increase fitness (a similar argument holds for destabilizing mutations).
However, the evidence for the additive folding energy hypothesis from DMS experiments has been mixed. Many studies have found a strong correlation between mutational effects on fitness and mutational effects on stability, including in proteins such as TEM-1 β-lactamase (36, 58) , the WW domain (4), nucleoprotein (7), and GFP (136) . Others, however, have found that mutational effects in the wild-type background are uncorrelated with stability effects (104) . And while global epistasis models can sometimes fit DMS data remarkably well (e.g., see Figure 5 ), other studies have revealed very different patterns of mutational effects. For instance, in a recent study, Starr et al. (155) showed that a large proportion of the mutations that have fixed over the evolutionary history of Hsp90 have fitness effects that have changed sign over evolutionary time. Similarly, and also in Hsp90, Bank et al. (11) conducted combinatorial mutagenesis at six sites and observed a pattern where the sign of a mutation's effect depended strongly on the sequence background. These results are incompatible with the additive folding energy hypothesis for Hsp90.
Another important challenge to the additive folding energy hypothesis comes from generative models for homologous proteins (80, 99) . While phylogenetic models of molecular evolution typically assume that each site in a protein evolves independently from the others and thus produces a long-term distribution of states described by an additive model (17, 51, 126, 163) models of protein alignments typically specify the log-likelihood of a sequence using a pairwise model that captures correlations between amino acids at (nonadjacent) pairs of positions (80) . By identifying pairs of sites whose interaction coefficients are unusually large, algorithms that use such pairwise models have shown highly impressive performance at predicting which residues are in direct physical contact in 3-D structures (99) . The presence of such pairwise interactions is also plausible from a functional modeling perspective; physicists have long worked with models of folding energy that consider the folding energy to be an additive function of sequence features restricted to sites that contact each other in the 3-D structure (97) . Another surprising property of these generative models with pairwise interactions is that they provide state-of-the-art performance in predicting the results of DMS assays; in one study, the performance of a pairwise model was far better than that of the corresponding additive score model (54) . Indeed, allowing not only pairwise but also higher-order interactions between sites, via the use of a type of deep learning model called a variational autoencoder (123) , can provide even better performance in predicting the results of DMS experiments. Thus, as in the modeling of DNA sequence specificity, generative models of protein sequence appear to provide excellent functional predictions, though the reasons for this remain unclear.
Case Study: Protein G
Many of the issues discussed above can be seen in the recent literature on protein G, an immunoglobulin-binding protein and model system for protein engineering studies. Olson et al. (104) conducted a DMS experiment based on mRNA display coupled to a pull-down assay using immunoglobulin G bound to beads. By quantifying the change in the frequency of variants before and after selection, they were able to measure enrichment ratios for all single and double mutations within a 56-amino-acid-long domain. [In a follow-up study, the same group also made similar measurements for all 20 4 = 160,000 possible combinations of amino acids at four particularly epistatic sites (175) .] Notably, almost no epistasis was observed between many pairs of mutations, particularly for mutations with small fitness effects. This lack of observed epistasis indicates an experiment of extremely high quality, since any noise would tend to produce spurious epistatic interactions. Contrary to the additive folding energy hypothesis, Olson et al. (104) found that the effects of mutations around the wild-type sequence, as quantified by enrichment ratios, were essentially uncorrelated with published measurements of the stability effects of mutations. However, they also somewhat surprisingly found that there were some mutant backgrounds where subsequent mutations had fitness effects that were well correlated with published stability effects (104, 176) . Otwinowski et al. (107) reanalyzed these double-mutant data by applying a global epistasis model. They confirmed that, while a global epistasis model provided an excellent fit to the data, the inferred coefficients for the additive part of the model remained uncorrelated with published stability effects. However, in a follow-up paper, Otwinowski (106) fit a more complex biophysical model (89) that treated the probability of a bound and folded complex as a function of both an underlying binding energy and a distinct underlying folding energy, both of which were additive functions of the sequence. In this apparently better-specified model, the inferred energetic effects were well correlated with the published energetic effects of mutations. Moreover, the model provided predictions for a large number of mutations whose energetic effects were unknown. These predictions were then dramatically confirmed by a subsequent high-throughput study that comprehensively measured the effects on free energy of folding for all point mutations in this protein (102) . While Otwinowski's (106) analysis would suggest that a model with two additive molecular phenotypes (folding energy and binding energy) is largely sufficient to explain the data, two other recent studies (128, 137) suggest that the picture is more complex. Analyzing the same data set, these groups were able to calculate the 3-D structure of the GB1 domain by inferring contacting residue pairs and then using these pairs as constraints for ab initio folding. Such a feat would be impossible if the model described by Otwinowski et al. (107) were complete, since both of the underlying phenotypes in that model were additive and so could not directly contain information about protein contacts. As it stands, the best current explanation is that the model with two underlying additive molecular phenotypes is approximately correct, but deviations from this model are still sufficient to enable the identification of residues that physically interact in the 3-D protein structure.
CIS-REGULATORY ELEMENTS
Studies of CREs contend with complications beyond those discussed in the previous section. As with proteins, epistatic interactions that straddle large portions of a CRE are often critical for function (20, 150) , and quantitative models that can accommodate such interactions are essential. But relative to proteins, much less is known about how CREs actually work. Except in exceedingly well-studied systems, such as the E. coli lac promoter (33) and the human interferon-β enhancer (109), the 3-D structures of CREs complexed with the proteins they scaffold have not been determined. Phylogenetic alignments of CREs across species are also less informative than alignments of proteins, as individual binding sites within CREs often appear and disappear on short evolutionary timescales (30, 85) .
Given these substantial challenges, MPRAs are proving to be a remarkably powerful technology for studying CRE biology on multiple scales. Using MPRAs, investigators can identify novel CREs and characterize their activities, quantify the effects of genetic variation within CREs, dissect specific CREs of interest in mechanistic detail, and characterize general features of cisregulatory grammar, i.e., the rules that govern how different combinations of binding sites within CREs combine to establish functionality. These different lines of investigation are enabled by mixing and matching different MPRA strategies (Figure 1 ) with different CRE sequence libraries (Figure 2) and, when appropriate, using quantitative models to explain the resulting data. We now review a few selected studies in order to illustrate this broad range of applications. (60) , on the other hand, developed an MPRA for identifying potentially useful bacterial promoters in large metagenomic databases. Using an oligo pool library comprising 29,249 candidate CREs drawn from 184 prokaryotic genomes, the authors performed a combination sort-seq/RNA-seq MPRA on three industrially important species of bacteria. Based on these data, they were then able to develop synthetic gene circuits that have species-specific activity.
Complementing the identification of novel genetic elements, Ulirsch et al. (167) and BaezaCenturion et al. (9) have illustrated two ways in which MPRAs can be used to study genetic variation. Ulirsch et al. (167) used an MPRA to study human genomic loci that had been previously identified in genome-wide association studies of red blood cell traits. Specifically, they used an RNA-seq MPRA to assay a library of human genomic sequences, as well as common variants thereof, for CRE activity. The authors identified 32 candidate loci for follow-up validation using CRISPR/Cas9 genome editing. One validated locus was found to regulate transcription of the gene RBM38, which was subsequently shown to encode an important regulator of alternative mRNA splicing in terminal erythropoiesis. Baeza-Centurion et al. (9) , by contrast, used an MPRA to study the effects that genomic substitutions across species have on splicing. They used an RNAseq MPRA to measure exon inclusion rates for 3,071 variants of FAS exon 6, representing all combinations of the 12 substitutions that are observed in this exon across the primate lineage. From the resulting data and follow-up studies, the authors identified a remarkably consistent and widespread global epistasis nonlinearity that links sequence variation to the probability of exon inclusion.
Many of the earliest MPRAs were designed to dissect specific CREs of interest at nucleotide resolution (69, 76, 95, 111, 112) , thereby providing insight into functional mechanisms. Melnikov et al. (95) used an RNA-seq MPRA to study two enhancers in this manner: a synthetic cAMP-responsive enhancer, and the human interferon-β enhancer. To this end, the authors used a combination of element scanning, systematic mutation, and scattered mutation libraries. For the cAMP-responsive enhancer, functional footprints clearly revealed the locations of binding sites for CREB, the cAMP-responsive TF that drives expression in this context. Functional footprints did not, however, resolve individual TF binding sites within the interferon-β enhancer. These divergent results likely reflect the difference between billboard enhancers and enhanceosomes (6, 150) : The cAMP-responsive enhancer is of the billboard type, as it has well-separated TF binding sites that are not strongly coupled; the interferon-β enhancer, on the other hand, forms the canonical example of an enhanceosome (108), a highly structured protein-DNA complex that is easily disrupted by changes to enhancer DNA sequence.
MPRAs can also be used for biophysical studies of in vivo TF-TF interactions that occur at specific CREs of interest. Kinney et al. (69) used a sort-seq MPRA to study a region of the E. coli lac promoter that contains binding sites for two proteins: CRP and the σ 70 RNA polymerase holoenzyme (RNAP). By fitting a thermodynamic model to their MPRA data, they were able to measure a value of −3.3 ± 0.4 kcal/mol for the cooperative interaction between these proteins, which allows CRP to upregulate transcription of the lac operon. Belliveau et al. (12) subsequently used this strategy, along with DNA affinity purification and mass spectrometry, to study E. coli promoters with little or no prior regulatory annotation. In doing so, they demonstrated a systematic method to identify novel TF binding sites, identify the TFs that bind those sites, and establish biophysical models for how those TFs carry out their regulatory functions. More recently, Forcier et al. (39) www.annualreviews.org • Quantitative Sequence-Function Relationships 20.19 Review in Advance first posted on May 15, 2019. (Changes may still occur before final publication.)
described an alternative MPRA-compatible strategy that substantially increases the precision and clarity with which TF-TF interactions can be measured in vivo.
Rather than focus on a specific CRE of interest, a variety of studies have used MPRAs in attempts to identify general principles that govern cis-regulatory grammar. Before the advent of high-throughput DNA sequencing, multiple groups investigated the levels of gene expression produced by artificial bacterial and yeast promoters comprising random arrangements of TF binding sites (24, 44, 84) . MPRAs subsequently allowed such studies to be performed in mammalian systems and on orders of magnitude more CREs (98, 149 ). An alternative approach for studying cis-regulatory grammar has been to use systematically varied synthetic CRE libraries. This strategy has been applied to a diverse range of CREs, including yeast promoters (87, 142) , yeast 5 and 3 UTRs (31, 140) , and human promoters (171) . MPRAs using fully random libraries have also been used in attempts to characterize cis-regulatory grammar relevant for yeast promoters (28) , yeast 5 UTRs (26) , and alternative splicing in human cells (129) .
General studies of cis-regulatory grammar have used a variety of quantitative modeling strategies, including statistical models (149) , thermodynamic models (44, 98) , and neural network models (26, 28, 129) . It remains largely unclear, however, which types of models work best in which situations. One potential way to clarify this issue would be to hold a quantitative modeling competition focused on cis-regulatory grammar, akin to the highly influential competition organized by Weirauch et al. (172) to assess methods for modeling TF specificity. Another potential way to validate models of cis-regulatory grammar is to perform follow-up studies that apply CRE-dissection MPRAs to a small number of specific CRE variants. For instance, these subsequent experiments might be able to verify model-predicted binding sites for trans factors, as well as interactions that are predicted by the model to occur between these trans factors. Indeed, combining general studies of cis-regulatory grammar with dissection studies on select CREs could prove to be a powerful way of using MPRAs to elucidate the complex sequence-function relationships that govern the regulation of gene expression.
CONCLUSION
We have reviewed recent progress in the development, analysis, and application of massively parallel assays. Although these high-throughput experiments have been used to investigate a broad range of biological phenomena, they share many key features, allowing them to be analyzed with a unified set of methods and concepts. Because variants remain pooled at each experimental step, these assays can have enormous throughput and can measure quantitative activities for thousands or even millions of variants in a single experiment. These capabilities suggest new strategies for addressing goals that previously had been barely imaginable, and here we have reviewed progress toward two such visions for contemporary genetics. These goals are quite different, and progress in multiple directions will be necessary to bring these efforts to fruition.
The first vision is to conduct comprehensive measurements of the phenotypic effects of all possible mutations to the most important and actionable human disease genes (56, 152, 169) . These prospective measurements would address the problem of genomic variant interpretation by providing patients and genetic counselors with direct evidence for the molecular phenotypes of mutations whose significance would otherwise be uncertain. While the gap between the molecular impact of individual mutations and their consequences at the level of the whole organism remains a substantial challenge (23) , comprehensive assays would reduce patient uncertainty by clearly distinguishing worrisome but ultimately benign mutations in disease genes from mutations that substantially affect molecular function and thus are likely to produce a disease state in at least some genetic backgrounds or environmental conditions. For this application, the key areas for progress GG20CH20_Kinney ARjats.cls May 6, 2019 15:22 primarily revolve around increasing the throughput, precision, replicability, and disease relevance of these high-throughput functional assays, so as to allow for the incorporation of these assays into revised versions of the clinical guidelines for diagnosis and treatment of genetic disease (122) . The second vision is to use massively parallel assays as a general-purpose technology to probe the mechanisms underlying the functionality of any given stretch of genomic DNA. We have reviewed the application of this methodology for understanding TF specificity, protein function, and the architecture of cis-regulatory sequences. We have also described some of the major open issues in these applications. Whereas the key areas for progress in variant interpretation are largely experimental, here the primary barrier to progress lies in the limitations of current quantitative modeling capabilities. Simple additive models provide crude but easily interpreted summaries of the sequence-function relationships revealed by high-throughput assays, and such models may in fact be sufficient in some applications, such as identifying likely TF binding sites. However, there is a strong need for models that can capture epistatic interactions of different types within more complex genetic elements, such as proteins and CREs. Most importantly, while it is clear that existing massively parallel assays are providing an unprecedented view of the richness and complexity of sequence-function relationships, better methods are needed to derive mechanistic insights from these observations.
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